LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Efficacy of DNK333 in Atopic Dermatitis Patients
- Status
- COMPLETED
- Phase
- PHASE2
To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
- Status
- TERMINATED
- Phase
- PHASE3
Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients
- Status
- TERMINATED
- Phase
- PHASE3
Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion
- Status
- COMPLETED
- Phase
- PHASE4
Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
- Status
- COMPLETED
- Phase
- PHASE2
CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Diclofenac Potassium Versus Acetaminophen in Febrile Children With Acute Upper Respiratory Tract Infections
- Status
- TERMINATED
- Phase
- PHASE4